Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David Peter Kao

TitleInstructor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED
Address2RB
Research Bridge
4200 East 9th Ave.
Denver CO 80262
Phone303/724-8308

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Katz DF, Sun J, Khatri V, Kao D, Bucher-Bartelson B, Traut C, Lundin-Martinez J, Goodman M, Mehler PS, Krantz MJ. QTc interval screening in an opioid treatment program. Am J Cardiol. 2013 Oct 1; 112(7):1013-8.
    View in: PubMed
  2. Kao D, Bucher Bartelson B, Khatri V, Dart R, Mehler PS, Katz D, Krantz MJ. Trends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry data. Ann Intern Med. 2013 May 21; 158(10):735-40.
    View in: PubMed
  3. Kao DP, Davis G, Aleong R, O'Connor CM, Fiuzat M, Carson PE, Anand IS, Plehn JF, Gottlieb SS, Silver MA, Lindenfeld J, Miller AB, White M, Murphy GA, Sauer W, Bristow MR. Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation. Eur J Heart Fail. 2013 Mar; 15(3):324-33.
    View in: PubMed
  4. Kao DP, Wagner BD, Robertson AD, Bristow MR, Lowes BD. A personalized BEST: characterization of latent clinical classes of nonischemic heart failure that predict outcomes and response to bucindolol. PLoS One. 2012; 7(11):e48184.
    View in: PubMed
  5. Kao DP, Hiatt WR, Krantz MJ. Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting. Pharmacotherapy. 2012 Aug; 32(8):767-71.
    View in: PubMed
  6. Kao DP, Martin MH, Das AK, Ruoss SJ. Consequences of federal patient transfer regulations: effect of the 2003 EMTALA revision on a tertiary referral center and evidence of possible misuse. Arch Intern Med. 2012 Jun 11; 172(11):891-2.
    View in: PubMed
  7. Kao DP, Kreso E, Fonarow GC, Krantz MJ. Characteristics and outcomes among heart failure patients with anemia and renal insufficiency with and without blood transfusions (public discharge data from California 2000-2006). Am J Cardiol. 2011 Jan; 107(1):69-73.
    View in: PubMed
  8. Yoon GJ, Telli ML, Kao DP, Matsuda KY, Carlson RW, Witteles RM. Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally? J Am Coll Cardiol. 2010 Nov 9; 56(20):1644-50.
    View in: PubMed
  9. Kao DP, Witteles RM, Quon A, Wu JC, Gambhir SS, Fowler MB. Rosiglitazone increases myocardial glucose metabolism in insulin-resistant cardiomyopathy. J Am Coll Cardiol. 2010 Mar 2; 55(9):926-7.
    View in: PubMed
  10. Kao DP. What can we learn from drug marketing efficiency? BMJ. 2008; 337:a2591.
    View in: PubMed
  11. Kao DP, Kohrt HE, Kugler J. Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use. Diabet Med. 2008 Oct; 25(10):1229-30.
    View in: PubMed
  12. Witteles RM, Kao D, Christopherson D, Matsuda K, Vagelos RH, Schreiber D, Fowler MB. Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol. 2007 Nov 6; 50(19):1835-40.
    View in: PubMed
Kao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_